Biblio
Export 81 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is U [Clear All Filters]
“The Price of Stress: High Bedtime Salivary Cortisol Levels Are Associated with Brain Atrophy and Cognitive Decline in Stroke Survivors. Results from the TABASCO Prospective Cohort Study.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1365-1375, 2018.
, “Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 63, no. 2, pp. 465-477, 2018.
, “Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer's Disease and Brain Aging.”, J Alzheimers Dis, vol. 61, no. 1, pp. 259-263, 2018.
, “Separating Symptomatic Alzheimer's Disease from Depression based on Structural MRI.”, J Alzheimers Dis, vol. 63, no. 1, pp. 353-363, 2018.
, “Tau Protein Dysfunction after Brain Ischemia.”, J Alzheimers Dis, vol. 66, no. 2, pp. 429-437, 2018.
, “Time Trends in the Prevalence of Neurocognitive Disorders and Cognitive Impairment in the United States: The Effects of Disease Severity and Improved Ascertainment.”, J Alzheimers Dis, vol. 64, no. 1, pp. 137-148, 2018.
, “TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1275-1284, 2018.
, “Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 1, pp. 273-280, 2019.
, “Mild Cognitive Impairment and Dementia Involving Multiple Cognitive Domains in Mexican Urbanites.”, J Alzheimers Dis, vol. 68, no. 3, pp. 1113-1123, 2019.
, “Two Year Outcomes, Cognitive and Behavioral Markers of Decline in Healthy, Cognitively Normal Older Persons with Global Deterioration Scale Stage 2 (Subjective Cognitive Decline with Impairment).”, J Alzheimers Dis, vol. 67, no. 2, pp. 685-705, 2019.
, “A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1381-1392, 2020.
, “A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1381-1392, 2020.
, “Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.”, J Alzheimers Dis, vol. 74, no. 1, pp. 127-138, 2020.
, “Individual Differences in the Effects of Physical Activity on Cognitive Function in People with Mild to Moderate Dementia.”, J Alzheimers Dis, vol. 74, no. 2, pp. 435-439, 2020.
, “Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1.”, J Alzheimers Dis, vol. 75, no. 1, pp. 173-185, 2020.
, “Waist Circumference and Domain-Specific Cognitive Function Among Non-Demented Japanese Older Adults Stratified by Sex: Results from the Takashima Cognition Study.”, J Alzheimers Dis, vol. 73, no. 3, pp. 887-896, 2020.
, “Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 80, no. 2, pp. 877-883, 2021.
, “The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1505-1527, 2021.
, “Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual.”, J Alzheimers Dis, vol. 85, no. 1, pp. 59-64, 2021.
, “A Novel Cognitive Function Scale Using Functional Near-Infrared Spectroscopy for Evaluating Cognitive Dysfunction.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1579-1588, 2021.
, “Research Attitudes and Interest Among Elderly Latinxs: The Impact of a Collaborative Video and Community Peers.”, J Alzheimers Dis, vol. 82, no. 2, pp. 771-779, 2021.
, “Impaired Experience-Dependent Refinement of Place Cells in a Rat Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1907-1916, 2022.
, “The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1039-1049, 2022.
, “Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.”, J Alzheimers Dis, vol. 94, no. 1, pp. 217-226, 2023.
, “Cross-Sectional Analysis of Periodontal Disease and Cognitive Impairment Conducted in a Memory Clinic: The Pearl Study.”, J Alzheimers Dis, vol. 96, no. 1, pp. 369-380, 2023.
,